Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2020-12-07 15:59:15
Reporting Period:
Accepted Time:
2020-12-07 15:59:15
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1668243 Urogen Pharma Ltd. URGN Pharmaceutical Preparations (2834) 000000000
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1763581 Mark Schoenberg 400 Alexander Park Drive
Princeton NJ 08540
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2020-12-04 1,042 $0.00 20,385 No 4 M Direct
Ordinary Shares Disposition 2020-12-04 662 $19.85 19,723 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Restricted Stock Units Disposition 2020-12-04 1,042 $0.00 1,042 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
  1. Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
  2. Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
  3. The reporting person was granted restricted stock units ("RSUs") on December 7, 2017 representing 12,500 ordinary shares. 33.33% of the RSUs vested on December 4, 2018 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter.